(9-133) Retrospective Study Comparing the Relapse Rate of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia After Front-Line Tyrosine Kinase Inhibitors

Wednesday, December 10, 2025

8:30 AM - 9:30 AM

Location: Bayside A, Level 1

Residency Program: Kaiser Permanente Medical Care Program, San Diego Pharmacy Operation
Residency Program Type: PGY2 (Oncology Pharmacy)
Residency Program Location: California

Co-Author(s): Angel O. Nguyen, Christine A. Voorhees

Primary Author(s)

Priscilla Bang, PharmD

Pharmacist resident
Kaiser Permanente